We are live on ! Find out more
EWM

Edge Wealth Management Portfolio holdings

AUM $594M
1-Year Est. Return 24.92%
This Fund
S&P 500
This Quarter Est. Return
+2.54%
1 Year Est. Return
+24.92%
3 Year Est. Return
+61.62%
5 Year Est. Return
+65.19%
10 Year Est. Return
+252.85%
AUM
$475M
AUM Growth
-$1M
Cap. Flow
-$8.95M
Cap. Flow %
-1.88%
Top 10 Hldgs %
58.1%
Holding
85
New
6
Increased
9
Reduced
40
Closed
7

Sector Composition

Rank Sector Weight
1 Technology 19.37%
2 Financials 10.29%
3 Industrials 9.55%
4 Communication Services 8.97%
5 Consumer Staples 6.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ETW
76
Eaton Vance Tax-Managed Global Buy-Write Opportunities Fund
ETW
$1.03B
$91K 0.02%
11,000
IHTA
77
DELISTED
Invesco High Income 2024 Target Term Fund
IHTA
$81.8K 0.02%
11,160
CGAU
78
Centerra Gold
CGAU
$3B
$68.5K 0.01%
10,200
AVDL
79
DELISTED
Avadel Pharmaceuticals
AVDL
-40,000
Closed -$676K
NIO icon
80
NIO
NIO
$12.2B
-12,000
Closed -$54K
PDI icon
81
PIMCO Dynamic Income Fund
PDI
$7.55B
-32,257
Closed -$622K
PFN
82
PIMCO Income Strategy Fund II
PFN
$704M
-19,800
Closed -$148K
TLT icon
83
iShares 20+ Year Treasury Bond ETF
TLT
$42.1B
-5,400
Closed -$511K
UBER icon
84
Uber
UBER
$147B
-4,170
Closed -$321K
V icon
85
Visa
V
$682B
-745
Closed -$208K

Similar funds

Edge Wealth Management's Q2 2024 Portfolio in Review

As of Q2 2024, Edge Wealth Management held 85 positions worth $475M, down 0.21% from $476M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Edge Wealth Management's Q2 2024 filing shows 6 new, 9 increased, 40 reduced and 7 closed positions. Its largest new stake was SLB Ltd: 182,842 shares worth $8.63M. The largest sale was Pfizer, an estimated $6.94M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Industrials.

  • Edge Wealth Management's largest Q2 2024 buy was SLB Ltd: 182,842 shares worth $8.63M.
  • Edge Wealth Management added most to iShares 3-7 Year Treasury Bond ETF in Q2 2024, an estimated $516K increase.
  • Edge Wealth Management's biggest Q2 2024 reduction was Pfizer, cutting an estimated $6.94M.
  • Edge Wealth Management fully exited Avadel Pharmaceuticals in Q2 2024, selling an estimated $676K.
  • Edge Wealth Management's ten largest holdings make up 58% of its $475M portfolio in Q2 2024.
  • Edge Wealth Management opened 6 new positions and closed 7 in Q2 2024.
  • Edge Wealth Management's portfolio value fell 0.21% quarter-over-quarter to $475M.

Based on Edge Wealth Management's 13F filing for Q2 2024, filed 12 Jul 2024.